Jay Trivedi

Dr. Jay Trivedi

Alpert Medical School, Brown University, Providence, Rhode Island, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
CSChristian Shigley
Christian Shigley
JTJay Trivedi
Jay Trivedi
OMOzair Meghani
Ozair Meghani
BOBrett D. Owens
Brett D. Owens
Chathuraka JayasuriyaChathuraka Jayasuriya
Chathuraka Jayasuriya
Current clinical strategies for restoring cartilage defects do not adequately consider taking the necessary steps to prevent the formation of hypertrophic tissue at injury sites. Chondrocyte hypertrophy inevitably causes both macroscopic and microscopic level changes in cartilage, resulting in adverse long-term outcomes following attempted restoration. Repairing/restoring articular cartilage while minimizing the risk of hypertrophic neo tissue formation represents an unmet clinical challenge. Previous investigations have extensively identified and characterized the biological mechanisms that regulate cartilage hypertrophy with preclinical studies now beginning to leverage this knowledge to help build better cartilage. In this comprehensive article, we will provide a summary of these biological mechanisms and systematically review the most cutting-edge strategies for circumventing this pathological hallmark of osteoarthritis.

18 August 2026 in Cells
Verified
Journal Article
Open access
PDF file
IWInes Wang
Ines Wang
BOBrett D. Owens
Brett D. Owens
JTJay Trivedi
Jay Trivedi
Tendinopathies represent a major clinical challenge. Vasculature, neuromuscular junctions, low cellularity, and slow extracellular matrix (ECM) turnover restrict endogenous repair and predispose injured tendons to fibrosis, mechanical weakness, and reinjury. Current therapeutic strategies including rehabilitation protocols, anti-inflammatory medications, platelet-rich plasma (PRP) injections, and surgical repair primarily address symptoms or structural deficits without correcting the underlying biological limitations of tendon healing. Cell-based therapies have emerged as a promising regenerative approach aimed at restoring tissue homeostasis through modulation of angiogenesis, collagen synthesis, immune responses, and tenogenic differentiation. Mesenchymal stem cells (MSCs), adipose-derived stem cells (ADSCs), tendon-derived stem cells (TDSCs), induced pluripotent stem cells (iPSCs), differentiated tenocytes, and extracellular vesicle (EV)-based products have demonstrated the ability to enhance vascularization, promote type I collagen remodeling, suppress excessive inflammation, and stimulate tenocyte lineage commitment. These effects are mediated through paracrine signaling, growth factor secretion, and activation of key pathways, including HIF-1α, TGF-β/SMAD, NF-κB, and PI3K/Akt signaling. Despite promising preclinical data, significant translational challenges remain, including limited cell survival at the injury site, variability in cell sources and dosing, immunogenicity, risk of misdifferentiation, and lack of standardization across clinical protocols. Emerging strategies such as genetic modification, hypoxic preconditioning, scaffold-based delivery systems, and extracellular vesicle engineering aim to enhance therapeutic efficacy and reproducibility. This review synthesizes current evidence on cell-based tendon repair, critically evaluates mechanistic insights, clinical trials, and translational barriers, and outlines future directions toward biologically informed regenerative therapies.

3 November 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
MCMaxwell Chen
Maxwell Chen
JTJay Trivedi
Jay Trivedi
Organ-on-chip (OoC) technology has emerged as a powerful class of microphysiological systems capable of recapitulating human tissue architecture, biochemical gradients, and dynamic cellular interactions with high fidelity. While OoC platforms have advanced rapidly in organs such as liver, heart, and lung, their application to the musculoskeletal system remains comparatively underdeveloped despite the central role of biomechanics in tissue function and disease. Musculoskeletal tissues, including skeletal muscle, bone, cartilage, and tendon, present unique challenges due to their hierarchical structure, anisotropic mechanical properties, and tightly coupled immune, vascular, and stromal interactions that govern repair and degeneration. In this review, we critically evaluate recent advances in musculoskeletal OoC platforms, including muscle, bone, cartilage, and tendon-on-chip systems, with emphasis on structural design, biomaterial composition, and integration of mechanical cues. We highlight how these systems enable precise control of microenvironmental conditions and support human-relevant disease modeling and drug testing. However, we identify key limitations that constrain their translational potential, including inadequate representation of physiologically relevant mechanical loading, incomplete vascular and immune integration, lack of standardization, and limited modeling of inter-tissue interfaces. Importantly, we propose a unifying framework for next-generation musculoskeletal OoC systems centered on three principles: mechanobiological fidelity, multicellular integration, and interface-level modeling of the muscle–tendon–bone axis. We further discuss emerging strategies, including advanced biomaterials, 3D bioprinting, multi-tissue integration, and artificial-intelligence-driven analysis that can address current limitations and enable scalable, predictive platforms. By bridging reductionist in vitro systems and complex in vivo physiology, musculoskeletal OoC technologies have the potential to transform mechanobiology research, accelerate drug discovery, and enable precision regenerative therapies. Realizing this potential will require coordinated advances in engineering, biology, and standardization to establish OoC platforms as robust, clinically relevant tools for musculoskeletal medicine.